MTP1023B - Hydrocinnamic acid derivatives - Google Patents

Hydrocinnamic acid derivatives

Info

Publication number
MTP1023B
MTP1023B MT1023A MTP1023A MTP1023B MT P1023 B MTP1023 B MT P1023B MT 1023 A MT1023 A MT 1023A MT P1023 A MTP1023 A MT P1023A MT P1023 B MTP1023 B MT P1023B
Authority
MT
Malta
Prior art keywords
acid derivatives
hydrocinnamic acid
hydrocinnamic
derivatives
acid
Prior art date
Application number
MT1023A
Other languages
English (en)
Inventor
Werner Aschwanden
Rene Imhof
Emilio Kyburz
Ronald Jakob-Roetne
Original Assignee
Hoffman Laroche And Co Aktieng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffman Laroche And Co Aktieng filed Critical Hoffman Laroche And Co Aktieng
Publication of MTP1023B publication Critical patent/MTP1023B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/31Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MT1023A 1987-07-21 1988-07-06 Hydrocinnamic acid derivatives MTP1023B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH276487 1987-07-21

Publications (1)

Publication Number Publication Date
MTP1023B true MTP1023B (en) 1989-07-18

Family

ID=4241087

Family Applications (1)

Application Number Title Priority Date Filing Date
MT1023A MTP1023B (en) 1987-07-21 1988-07-06 Hydrocinnamic acid derivatives

Country Status (25)

Country Link
US (2) US4883815A (es)
EP (1) EP0300371A1 (es)
JP (1) JPS6447748A (es)
KR (1) KR890001954A (es)
CN (1) CN1015622B (es)
AU (1) AU603470B2 (es)
DD (1) DD277071A5 (es)
DK (1) DK405888A (es)
FI (1) FI883441A (es)
GB (1) GB2207135B (es)
HU (1) HU198676B (es)
IL (1) IL87130A0 (es)
IN (1) IN167395B (es)
IS (1) IS3376A7 (es)
MC (1) MC1960A1 (es)
MT (1) MTP1023B (es)
MW (1) MW2688A1 (es)
NO (1) NO883233L (es)
NZ (1) NZ225442A (es)
OA (1) OA08746A (es)
PT (1) PT88041A (es)
TN (1) TNSN88076A1 (es)
YU (2) YU141488A (es)
ZA (1) ZA885102B (es)
ZW (1) ZW9288A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250539A (en) * 1991-08-21 1993-10-05 Eli Lilly And Company Hexahydrobenzo[f]quinolinones
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
EP0591582B1 (en) * 1991-08-21 1999-01-20 Eli Lilly And Company Hexahydrobenzo (f) quinolinones as 5-alpha-reductase inhibitors
US5574054A (en) * 1992-05-12 1996-11-12 Zeria Pharmaceutical Co., Ltd. Quaternary ammonium salts and use thereof as medicine
DE69725455T2 (de) * 1996-08-09 2004-08-12 Merck & Co., Inc. Additionsreaktion mit asymmetrischem konjugat
US6172235B1 (en) 1996-08-09 2001-01-09 Merck & Co., Inc. Asymmetric conjugate addition reaction
US5849914A (en) * 1996-08-09 1998-12-15 Merck & Co., Inc. Compounds formed by an asymmetric conjugate addition reaction
GB9920872D0 (en) * 1999-09-04 1999-11-10 Glaxo Group Ltd Benzophenones as inhibitors of reverse transcriptase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3795683A (en) * 1970-08-19 1974-03-05 Hoffmann La Roche 2,3,4,5-tetrahydro-1h-3-benzazepines
JPS6033439B2 (ja) * 1980-03-07 1985-08-02 財団法人相模中央化学研究所 ジペプチドの製造方法
IT1175926B (it) * 1984-01-13 1987-08-12 Debi Derivati Biologici Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenilalanina
DE3773950D1 (de) * 1986-01-23 1991-11-28 Hoffmann La Roche Benzazecin-derivate.

Also Published As

Publication number Publication date
FI883441A0 (fi) 1988-07-20
YU39890A (en) 1991-10-31
GB2207135A (en) 1989-01-25
FI883441A (fi) 1989-01-22
YU141488A (en) 1990-06-30
OA08746A (fr) 1989-03-31
NO883233L (no) 1989-01-23
GB8817291D0 (en) 1988-08-24
HU198676B (en) 1989-11-28
GB2207135B (en) 1991-05-15
IL87130A0 (en) 1988-12-30
AU603470B2 (en) 1990-11-15
EP0300371A1 (de) 1989-01-25
CN1036952A (zh) 1989-11-08
ZW9288A1 (en) 1989-02-01
IS3376A7 (is) 1989-01-22
DD277071A5 (de) 1990-03-21
CN1015622B (zh) 1992-02-26
MW2688A1 (en) 1989-04-12
HUT47077A (en) 1989-01-30
PT88041A (pt) 1989-06-30
US4883815A (en) 1989-11-28
KR890001954A (ko) 1989-04-06
JPS6447748A (en) 1989-02-22
DK405888A (da) 1989-01-22
NZ225442A (en) 1991-05-28
DK405888D0 (da) 1988-07-20
US5017608A (en) 1991-05-21
TNSN88076A1 (fr) 1990-07-10
IN167395B (es) 1990-10-20
AU1917688A (en) 1989-01-27
MC1960A1 (fr) 1989-06-30
ZA885102B (en) 1989-03-29
NO883233D0 (no) 1988-07-20

Similar Documents

Publication Publication Date Title
GB2207672B (en) Sulphonamidothienylcarboxyic acid compounds
EP0291245A3 (en) Benzoylaminophenoxybutanoic acid derivatives
GB2203149B (en) New ribofuranuronic acid derivatives
ZA882347B (en) Amino acid derivatives
ZA887322B (en) Amino acid derivatives
GB2207135B (en) Hydrocinnamic acid derivatives
GB8703749D0 (en) Piperazinecarboxylic acid
ZA887373B (en) Amino acid derivatives
GB2207428B (en) Naphthalenepropionic acid derivatives
ZA883782B (en) Amino acid derivatives
EP0421752A3 (en) Substituted acrylamido-penicillanic acid derivatives
ZA903999B (en) Mevinic acid derivatives
GB8707515D0 (en) Amino acid derivatives
JPS6413096A (en) 1-aminoethylphosphinic acid derivative
JPS6413095A (en) 1-aminoethylphosphinic acid
IE871285L (en) 2-cyanonicotinic acid derivatives
IE873378L (en) Furanuronic acid derivatives
ZA882384B (en) New ribofuranuronic acid derivatives
IE872256L (en) Thiopenem-carboxylic acid derivative
ZA908085B (en) Imidazole-hept-6-enoic acid derivatives
IE893838L (en) ß-AMINOBORONIC ACID DERIVATIVES
GB8918937D0 (en) Acid derivatives
ZA902133B (en) Acrylamido-penicillanic acid derivatives
GB8710781D0 (en) 3-hydroxy-3-methylpentanedioic acid
GB8703750D0 (en) Piperazinecarboxylic acid